Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 10, 2010, Pages 2258-2260

  du Plessis, Mignon ^a,b   de Gouveia, Linda ^a,b   Skosana, Happy ^a   Thomas, Juno ^a   Blumberg, Lucille ^a   Klugman, Keith P ^b,c   von Gottberg, Anne ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprophylaxis; Meningococcal disease; Meningococcus; South Africa

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; NALIDIXIC ACID; NITROCEFIN; OFLOXACIN; PENICILLIN G; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CEREBROSPINAL FLUID CULTURE; GENE SEQUENCE; LETTER; MENINGOCOCCEMIA; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; SOUTH AFRICA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CEFTRIAXONE; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MENINGITIS, MENINGOCOCCAL; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA; TRAVEL;

EID: 77957232747     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq291     Document Type: Letter

References (13)

1. Skoczynska A, Alonso JM, Taha MK. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg Infect Dis 2008; 14: 1322-3.
2. Chu YW, Cheung TK, Tung V et al. A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong. Int J Antimicrob Agents 2007; 30: 94-5.
3. Shultz TR, Tapsall JW, White PA et al. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob Agents Chemother 2000; 44: 1116.
4. Alcala B, Salcedo C, de la Fuente L et al. Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain. J Antimicrob Chemother 2004; 53: 409.
5. Corso A, Faccone D, Miranda M et al. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J Antimicrob Chemother 2005; 55: 596-7.
6. Singhal S, Purnapatre KP, Kalia V et al. Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis 2007; 13: 1614-6.
7. CDC. Emergence of fluoroquinolone-resistant Neisseria meningitidis-Minnesota and North Dakota, 2007-2008. MMWR Morb Mortal Wkly Rep 2008; 57: 173-5.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
9. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA, 2004.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
11. du Plessis M, von Gottberg A, Cohen C et al. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J Clin Microbiol 2008; 46: 3208-14.
12. Wu HM, Harcourt BH, Hatcher CP et al. Emergence of ciprofloxacinresistant Neisseria meningitidis in North America. New Engl J Med 2009; 360: 886-92.
13. Shultz TR, White PA, Tapsall JW. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob Agents Chemother 2005; 49: 1753-60.